Effects of halothane on action potential con®guration in subendocardial and sub-epicardial myocytes from normotensive and hypertensive rat left ventricle Background. Halothane shortens ventricular action potential duration (APD), as a consequence of its inhibitory effects on a variety of membrane currents, an effect that is greater in sub-endocardial than sub-epicardial myocytes. In hypertrophied ventricle, APD is prolonged as a consequence of electrical remodelling. In this study, we compared the effects of halothane on transmural APD in myocytes from normal and hypertrophied ventricle.
Methods. Myocytes were isolated from the sub-endocardium and sub-epicardium of the left ventricle of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. Action potentials were recorded before, during, and after a 1-min exposure to 0.6 mM halothane and APD measured from the peak of the action potential to repolarization at ±50 mV (APD ±50 mV ). Data are presented as mean (SEM). During the development of ventricular hypertrophy, remodelling of the myocardium occurs, 1 which leads to changes in the expression of various proteins crucial to the normal electrical and contractile function of the heart. As a consequence, the ventricular action potential is prolonged, 2 which is thought to result predominantly from a decreased expression of the transient outward K + current (I to ) rather than changes in the L-type Ca 2+ current (I Ca ) or other K + currents. 3 Exposure to halothane leads to a reduction in ventricular action potential duration 4 5 secondary to inhibition of both inward and outward membrane currents (e.g. I Ca 6 and I to 7 ). Recently, it has been reported 8 that halothane abbreviates action potential duration (APD) to a greater extent in left ventricular sub-endocardial than sub-epicardial myocytes and it was proposed that the transmural gradient in expression of I to 9 contributed to this effect. As several halothanesensitive currents are affected during hypertrophic remodelling (e.g. I to ), our aim was to investigate whether halothane affected the action potential differentially in hypertensive and normotensive ventricle. 
Methods and results
Left ventricular sub-epicardial and sub-endocardial myocytes were dissociated enzymatically 8 from 20-week-old Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats (Harlan UK, Oxon, UK). Myocytes were superfused with the following solution (in mM): NaCl 140; KCl 5.4; MgCl 2 1.2; NaH 2 PO 4 0.4; HEPES 5; glucose 10; CaCl 2 1; pH 7.4 (NaOH) at 30°C. Halothane 0.6 mM was added from a 0.5 M stock solution made up in dimethyl sulphoxide. Action potentials were recorded using the perforated patch clamp technique in current clamp mode (Axoclamp 200A, Axon Instruments, Inc., Foster City, CA, USA).
8 APD was measured from the peak of the action potential to repolarization at ±50 mV (APD ±50 mV ). Statistical comparisons were carried out with Student's ttests (paired or unpaired as appropriate) or ANOVA followed by corrected t-tests (Tukey) for multiple comparisons. Data are presented as mean (SEM).
SHR myocytes were signi®cantly longer (145 (4) mm, n=27) than WKY myocytes (128 (4) mm, n=28; P=0.005, t-test); however, the degree of hypertrophy was regional; myocyte length was greater in sub-endocardial (SHR, 148 (4) mm vs WKY, 123 (6) mm; P<0.05) than sub-epicardial myocytes (SHR, 141 (7) mm vs WKY, 134 (4) mm; P>0.05).
In WKY, APD ±50 mV was shorter (P=0.003) in subepicardial myocytes (21 (2) ms, n=15) than sub-endocardial myocytes (37 (4) ms, n=14; Fig. 1 ). Halothane reduced APD ±50 mV to 18 (2) ms (P<0.001) in sub-epicardial myocytes and to 28 (3) ms (P<0.001) in sub-endocardial myocytes. In SHR myocytes, APD ±50 mV values were prolonged compared with WKY and APD ±50 mV was reduced from 36 (6) to 27 (4) ms (P<0.016), and from 77 (10) to 38 (4) ms (P<0.001) by halothane in sub-epicardial and sub-endocardial myocytes, respectively. Halothane did not affect the resting membrane potential in either WKY or SHR myocytes although action potential amplitude was depressed signi®cantly by halothane in all cells (P<0.05).
Comments
These data are the ®rst to describe the effects of halothane on action potential con®guration in hypertrophied ventricle. Two major points arise from this study. The ®rst is that hypertrophy was not homogeneous across the ventricular wall; hypertrophy (measured as an increase in cell length) was greater in cells from the sub-endocardium than subepicardium. Wall stress is known to be greater at the subendocardial than sub-epicardial surface of the heart. 10 This gradient may be the reason for the selective hypertrophy of sub-endocardial myocytes and this may be causally related to the greater prolongation of APD noted in SHR subendocardial cells (Fig. 1) . 2 The second main point of this study is that exposure to a clinically relevant concentration of halothane (approximately twice the minimum alveolar concentration) had a greater proportionate inhibitory effect on APD in hypertrophied than in normotensive myocytes, especially in subendocardial cells (Fig. 1 ). As such, the transmural gradient of repolarization in SHR was reduced to 27% of its control value by halothane, and APD ±50 mV was no longer signi®cantly different between the sub-endocardium and sub-epicardium in the presence of halothane. This effect was greater than observed in WKY myocytes where the transmural gradient of APD was reduced to 63% of its control value by halothane.
In summary, the data show that halothane reduces APD, which could potentially reduce the incidence of re-entrant arrhythmias in the hypertrophied ventricle by reducing the increased transmural dispersion of repolarization/refractoriness. However, as sub-endocardial APD was reduced dramatically by halothane, the transmural gradient in APD ±50 mV was essentially abolished in the SHR and this may also impact on repolarization in hypertrophied ventricle.
